Target intelligence / Profile preview

Microbiome and host ecosystem components

Molecular classification
Other, Biological ecosystem
01

Overview

The microbiome and host ecosystem components refer to the collective community of microorganisms—including bacteria, fungi, viruses, and archaea—and their complex symbiotic interactions with human cells and tissues [1]. This ecosystem is not a single molecular target but a functional biological system that plays a critical role in nutrient metabolism, the synthesis of essential vitamins, and the maturation and regulation of the host immune system [2]. Disruptions to this delicate balance, a state known as dysbiosis, are associated with a wide range of pathologies, including Clostridioides difficile infection, inflammatory bowel disease (IBD), and metabolic disorders like obesity [3, 4]. Therapeutic strategies targeting this ecosystem often involve the introduction of beneficial microbes (probiotics) or substrates (prebiotics) to shift population dynamics toward a healthy state [5]. Modern interventions, such as fecal microbiota transplants and FDA-approved live biotherapeutic products, aim to restore ecological stability and competitive exclusion of pathogens rather than inhibiting a specific host protein [3, 5].

Other names
Human microbiotaGut floraCommensal microbiomeMicrobiota-host interfaceMicrobial ecosystemHolobiont components
02

Mechanism of action

Restoration of microbial diversity and ecological competition to suppress pathogen overgrowth and modulate host immune signaling through the production of metabolites like short-chain fatty acids [2, 4].

03

Biological functions

Metabolic regulationImmune system modulationPathogen exclusionVitamin synthesisMucosal barrier maintenanceNeurotransmitter production
04

Disease associations

InfectionInflammationMetabolic syndromeGastrointestinal disordersAutoimmune diseaseNeurodegenerative disease
05

Safety considerations

Risk of opportunistic infections or bacteremiaTransfer of antimicrobial resistance (AMR) genesVariable patient response due to baseline microbiome heterogeneityPotential for unintended systemic inflammatory responses
06

Interacting drugs

Fecal microbiota spores-rpbr (Vowst)

5 more in the full profile.

07

Biomarkers

Microbial diversity (Shannon index)Firmicutes/Bacteroidetes ratioShort-chain fatty acid (SCFA) levelsFecal calprotectin16S rRNA sequencing profiles

Beyond the preview

Go deeper on Microbiome and host ecosystem components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbiome and host ecosystem components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call